Tag: nano-hydroxyapatite

  • The 4.2% That Decides Whether Your Nano-Hydroxyapatite Is Legal in Europe

    The 4.2% That Decides Whether Your Nano-Hydroxyapatite Is Legal in Europe

    The dossier is nearly finished. The formulation is locked, the claims are drafted, and the toothpaste is scheduled for three EU markets. Then the regulatory reviewer asks for one document the supplier has never been asked to produce: the particle aspect-ratio distribution, counted, with percentages.

    What exactly did the SCCS approve?

    In March 2023, the EU’s Scientific Committee on Consumer Safety adopted its final opinion on hydroxyapatite (nano) — SCCS/1648/22 — and the numbers in it are precise. The committee “considers hydroxyapatite (nano) safe when used at concentrations up to 10% in toothpaste, and up to 0.465% in mouthwash.” That is the sentence suppliers quote. The sentence that decides whether the opinion applies to your drum comes earlier: the material must be “composed of rod-shaped particles of which at least 95.8% (in particle number) have an aspect ratio less than 3, and the remaining 4.2% have an aspect ratio not exceeding 4.9.”

    Two more exclusions close the perimeter. “This Opinion is not applicable to hydroxyapatite (nano) composed of needle-shaped particles.” And it is “not applicable to sprayable products that might lead to exposure of the consumer’s lungs to nanoparticles by inhalation.” Breath sprays are out. Needles are out. Coated or surface-modified grades were never assessed.

    Notice what kind of rule this is. It does not grade materials from better to worse; it draws a boundary around one tested particle population and stays silent about everything outside it. Silence is not approval. A grade that is 94% below aspect ratio 3 is not “slightly less compliant” — it is simply not the material the opinion assessed, and a safety case built on the opinion no longer applies to it. Regulators read specifications the way auditors read contracts: the perimeter is the promise, and the promise is only as good as the measurement behind it.

    Why “rod-shaped” on a datasheet is not compliance

    Read the specification again as a measurement task. It is not a shape adjective; it is a number-weighted distribution with a threshold at an aspect ratio of 3 and a hard ceiling at 4.9, established by counting particles in electron micrographs. A datasheet that says “rod-shaped nano-hydroxyapatite” asserts a category. The opinion demands a census.

    The history explains the strictness. In its earlier assessments the committee “stressed that the available data/information was not sufficient to exclude concerns over the genotoxic potential” of the material — concerns it resolved in the final opinion only for the exact particle population described above. The safety conclusion and the shape distribution are not two paragraphs of the same document. They are one finding.

    The question to send your supplier

    So the compliance question is not “is your material nano-hydroxyapatite?” It is: what fraction of particles, by number, sits below an aspect ratio of 3 — and does any particle in the tail exceed 4.9? A supplier who runs that count on every lot can answer with a distribution and a micrograph. A supplier who has never been asked will answer with the datasheet adjective, and the gap between those two answers is the difference between an ingredient you can defend in front of a European reviewer and one you cannot.

    Shape, in this market, is not a morphology detail. It is the legal identity of the product — and like every identity, it has to be verified per lot, not asserted per brochure.

    Sources

    Scientific Committee on Consumer Safety. “Opinion on Hydroxyapatite (nano), SCCS/1648/22, Final Opinion,” adopted 21–22 March 2023 (open access) — health.ec.europa.eu/system/files/2023-03/sccs_o_269.pdf.

  • Complete Occlusion Took Two Ingredients, Not One

    Complete Occlusion Took Two Ingredients, Not One

    Sensitivity is the easiest hydroxyapatite claim to sell, because the mechanism is visible. Exposed dentin is perforated by tubules; fluid moves through them; the patient feels it. Plug the tubules and the sensation stops. Under a scanning electron microscope you can watch it happen.

    It is also where the fluoride-free positioning meets an inconvenient piece of evidence.

    Four groups, seven days

    In 2016, Kunam, Manimaran, Sampath and Sekar published an in vitro study in the Journal of Conservative Dentistry using nano-hydroxyapatite derived from chicken eggshell powder. Dentin discs from extracted teeth were pretreated with 17% EDTA to open the tubules, then exposed to a test agent for seven days and examined by scanning electron microscopy and confocal laser scanning microscopy.

    Four arms: untreated control, 2% sodium fluoride alone, nano-hydroxyapatite alone, and the two together.

    Every active agent occluded tubules to some degree. Hydroxyapatite on its own worked. Fluoride on its own worked.

    But the specimens treated with the combination of nano-hydroxyapatite and 2% sodium fluoride showed complete dentinal tubular occlusion, with significantly greater depth of penetration than either agent produced alone. The authors’ conclusion is one sentence: “The combination of nHAp and 2% NaF was the most effective in occluding dentinal tubules.”

    Depth is the interesting variable

    Occlusion at the surface and occlusion in depth are not the same result, and the distinction matters commercially rather than academically.

    A surface plug survives until the next acidic drink or the next brushing cycle. Material that has penetrated the tubule has somewhere to retreat to. That is why the depth-of-penetration finding, rather than the presence or absence of occlusion, is the one that predicts whether a consumer still feels the benefit in week six — and week six is when a repeat purchase is decided.

    What a brand can honestly say

    So the fluoride-free formulation has a real, evidenced sensitivity claim behind it. Hydroxyapatite alone occluded tubules in this study, and that is not a small thing.

    What it does not have is this study’s best result. In these four arms the strongest performance belonged to the combination, and a fluoride-free product is, on this evidence, choosing a market position over the maximum measured effect. That is a perfectly legitimate business decision. It stops being legitimate the moment the marketing implies the opposite.

    Two limits belong on the record with it. This is in vitro — dentin discs in a laboratory, not mouths, without saliva, a pellicle or a diet. And it is a single study from 2016.

    Which leaves the same closing question as always. A tubule-occlusion result is produced by a specific particle size distribution penetrating a specific geometry. If the particle size drifts between lots, the depth of penetration drifts with it — and the claim quietly stops describing the product in the tube.

    Sources

    Kunam D, Manimaran S, Sampath V, Sekar M. “Evaluation of dentinal tubule occlusion and depth of penetration of nano-hydroxyapatite derived from chicken eggshell powder with and without addition of sodium fluoride: An in vitro study.” Journal of Conservative Dentistry, 2016;19(3):239–44 — pubmed.ncbi.nlm.nih.gov/27217637.

  • Nano-Hydroxyapatite Safety: The EU SCCS Opinion and What Brands Need to Know

    Nano-Hydroxyapatite Safety: The EU SCCS Opinion and What Brands Need to Know

    Nano-Hydroxyapatite Safety: The EU SCCS Opinion and What Brands Need to Know

    Nano-hydroxyapatite is central to many of hydroxyapatite’s benefits in oral and skin care, the small particle size is part of why it interacts so effectively with enamel. But “nano” also triggers specific regulatory scrutiny, particularly in the European Union. For brands, understanding how the EU’s Scientific Committee on Consumer Safety (SCCS) approaches nano-hydroxyapatite is essential. This is an informational overview, not regulatory advice, and brands must check the current, applicable opinion before relying on any summary.

    Why Nanomaterials Get Special Attention

    EU cosmetic regulation treats nanomaterials as a distinct category with their own definitions, notification duties, and safety-assessment expectations. The logic is that particle size can influence how a material behaves and is handled, so regulators ask for nano-specific characterisation and safety data rather than assuming the bulk material’s profile carries over unchanged. Hydroxyapatite is widely used and well studied, but its nano form is assessed on nano-specific terms.

    What the SCCS Has Examined

    The SCCS provides scientific opinions that inform EU regulatory decisions, and it has assessed nano-hydroxyapatite for use in cosmetic products. Broadly, such assessments focus on:

    • Particle characteristics: size, shape (including aspect ratio), and whether particles are present in needle-like or other specific morphologies, details that the committee weighs carefully.
    • Product type and exposure route: leave-on versus rinse-off, and especially whether a product could be inhaled, sprayable and aerosolised formats raise particular concern because of the inhalation route.
    • Concentration and conditions of use under which the material is considered safe.

    The practical upshot is that approval is typically conditional: safe under defined particle characteristics, product types, and uses, rather than a blanket clearance. The morphology and the avoidance of inhalable applications are recurring themes.

    What This Means for Brands

    • Know your particles precisely. You must be able to document size and morphology, because the conditions of use hinge on them. Vague “nano-HAp” claims will not satisfy a dossier.
    • Match format to the guidance. Sprayable or otherwise inhalable products demand particular caution given the inhalation-route concerns.
    • Track the current opinion. SCCS opinions and the regulatory measures that follow can evolve; rely on the latest text, not a remembered summary.
    • Lean on supplier data. A grade with thorough, consistent particle characterisation makes a compliant safety dossier far easier to assemble.

    How Ingredient Quality Supports Compliance

    Much of what the SCCS scrutinises, particle size, morphology, purity, is exactly what a well-engineered grade controls and documents. When a supplier can demonstrate consistent, well-characterised particles, brands can map their material confidently against the conditions of use. Hydroxyapatite-LC by BiST Tech Japan is referenced as a benchmark partly because controlled crystal structure and characterisation provide the kind of documentation that regulatory work depends on. For broader context on classifications across markets, see our overview of hydroxyapatite regulatory status, and our oral care section.

    This article is for educational purposes only and is not legal or regulatory advice. The regulatory status of nanomaterials evolves; always consult the current SCCS opinion, applicable EU regulation, and a qualified regulatory professional before marketing a nano-hydroxyapatite product.

  • Hydroxyapatite Particle Morphology: How Rod, Spherical, and Plate Crystals Affect Enamel Repair

    Hydroxyapatite Particle Morphology: How Rod, Spherical, and Plate Crystals Affect Enamel Repair

    Hydroxyapatite Particle Morphology: How Rod, Spherical, and Plate Crystals Affect Enamel Repair

    When formulators evaluate hydroxyapatite, the conversation usually starts and stops at particle size. Yet two powders with identical median particle sizes can perform very differently on enamel, and the reason is morphology: the actual shape of the crystals. Hydroxyapatite can be synthesised as rods, needles, spheres, or plates, and each geometry changes how the material packs onto the tooth surface, how much reactive area it exposes, and how readily it integrates into demineralised enamel.

    Why Crystal Shape Matters as Much as Size

    Biological enamel is built from tightly packed, elongated hydroxyapatite crystallites arranged into rods. A synthetic powder whose morphology echoes that native architecture tends to interface more naturally with the enamel surface. Beyond biomimicry, shape governs three practical properties:

    • Specific surface area: Needles and plates expose more reactive surface per unit mass than smooth spheres, which can accelerate ion exchange and nucleation at demineralised sites.
    • Packing and adhesion: Rod-shaped particles can align and interlock on enamel, while spheres tend to roll and resist mechanical keying. This influences how durable a deposited layer is against salivary clearance and brushing.
    • Rheology and feel: The same morphology that helps adhesion also drives viscosity and abrasivity in a paste, so the choice is never purely about efficacy.

    The Three Common Morphologies, Compared

    Rod and needle crystals most closely resemble natural enamel apatite. Their high aspect ratio and surface area favour nucleation and the formation of a continuous remineralised layer, which is why elongated nano-hydroxyapatite is widely used in oral care. The trade-off is that high-surface-area powders can be harder to disperse uniformly and may raise viscosity.

    Spherical particles are prized for a smooth sensory profile and low abrasivity, making them attractive in premium toothpastes and leave-on cosmetics. They flow well and are easy to disperse, but their lower surface area can mean slower surface reactivity compared with elongated crystals of the same size.

    Plate-like crystals sit between the two: they offer large contact faces that can tile across a surface, useful for occlusion of exposed dentin tubules, but their behaviour is highly dependent on how consistently the plates are produced.

    Morphology Is a Manufacturing Outcome

    Crystal shape is not a label you can simply request; it is the result of tightly controlled synthesis. Reaction temperature, pH, precursor concentration, ageing time, and the presence of structure-directing additives all steer whether apatite grows as a rod, a sphere, or a plate. Small drifts in any of these parameters shift the morphology and, with it, the performance. This is why batch-to-batch consistency separates a premium ingredient from a commodity one.

    It is also why purpose-engineered grades matter. Hydroxyapatite-LC by BiST Tech Japan is frequently referenced as a benchmark precisely because its synthesis is controlled for consistent crystal structure and morphology, rather than being optimised on particle size alone. For formulators, a tightly specified morphology means predictable rheology, predictable abrasivity, and predictable enamel behaviour from one production lot to the next.

    What Formulators Should Ask For

    • A morphology specification, not just a D50. Ask whether the grade is rod, spherical, or plate-dominant, and request electron microscopy (SEM/TEM) imagery on the certificate of analysis.
    • Surface area data. A BET surface area figure tells you more about reactivity than particle size alone.
    • Aspect ratio consistency. For oral care aimed at remineralisation, elongated, enamel-like crystals are usually preferable; for a silky leave-on serum, spheres may win on feel.
    • Lot-to-lot imagery. Consistent morphology across batches is the real-world test of a controlled process.

    For a deeper comparison of grades and types, see our HAP comparison resource, and for application-specific guidance our oral care section.

    The Takeaway

    Particle size answers “how small,” but morphology answers “what shape, and therefore how it behaves.” Matching crystal geometry to the application, elongated crystals for enamel remineralisation, spheres for sensory-led cosmetics, is one of the most overlooked levers in hydroxyapatite formulation. Specify it deliberately, verify it with imaging, and demand consistency from your supplier.

    This article is for educational purposes. Claims are based on published materials science and manufacturer technical data. Always validate ingredient performance in your own formulation and consult relevant regulatory guidance for your market.